Continuous Bioprocessing Market: Pharmaceuticals Lead End-Users as Biotechnology and CDMOs Drive Growth
The [Continuous Bioprocessing Market] is powered by a diverse range of end-users, with pharmaceutical companies currently representing the largest segment. Their dominance is driven by the need to manufacture blockbuster biologics like monoclonal antibodies at scale, while managing costs and meeting strict regulatory standards . However, the market is witnessing a significant...
0 Comments 0 Shares 72 Views 0 Reviews